SATIVEX; a CANNABIS-BASED pain-killer on sale in Canada 6-20-05
Canada's decision comes just in time for those who benefited from the use of medical marijuana and wish to continue to use it, with a Doctor's prescription.
Consider the following news items about Sativex, collected from a variety of sources.
- Sativex, cannabis-based painkiller for multiple sclerosis patients went on sale Monday in Canada, the first country to approve the spray derived from the marijuana plant. Sativex can now be obtained by prescription through Canadian pharmacies, Bayer HealthCare announced Monday. Bayer markets the drug in Canada for British drug company GW Pharmaceuticals, which developed the drug.
- Developed by GW Pharmaceuticals, Sativex is a whole plant medicinal cannabis extract indicated for relief of symptoms of multiple sclerosis (MS) and for treatment of severe neuropathic pain. Bayer has secured exclusive rights to market Sativex in the UK with the option to extend this to other countries in Europe and Commonwealth countries such as Canada.
- Sativex is a medicinal mouth spray developed from the major components of marijuana, including tetrahydrocannabinol (THC) and cannabidiol (CBD). It would be the first prescription drug that uses real marijuana extracts and not a synthesized form, according to its proponents.
- Early trials of the drug in Britain showed that it was a safe and effective treatment to relieve painful symptoms of multiple sclerosis.
Great news for those who thought that their options for reducing pain had just been reduced.